Fertility and Sterility
Volume 91, Issue 6 , Pages 2455-2460 , June 2009

Providing fertility care to men seropositive for human immunodeficiency virus: reviewing 10 years of experience and 420 consecutive cycles of in vitro fertilization and intracytoplasmic sperm injection

Received 6 March 2008 ,Revised 4 April 2008 ,Accepted 4 April 2008.

References 

  1. Semprini AE, Levi-Setti P, Bozzo M, Ravizza M, Taglioretti A, Sulpizio P, et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet. 1992;340:1317–1319
  2. Smith JR, Forster GE, Kitchen VS, Hooi YS, Munday PE, Paintin DB. Infertility management in HIV positive couples: a dilemma. BMJ. 1991;302:1447–1450
  3. Sauer MV. Sperm washing techniques address the fertility needs of HIV-seropositive men: a clinical review. Reprod Biomed Online. 2005;10:135–140
  4. Committee on Ethics of the American College of Obstetricians and Gynecologists. Committee on Ethics of the American College of Obstetricians and Gynaecologists. Human immunodeficiency virus: physicians' responsibilities. ACOG Committee Opinion: No. 255, April 2001.
  5. Human immunodeficiency virus and infertility treatment. Fertil Steril. 2004;82(Suppl 1):S228–S231
  6. Gilling-Smith C, Nicopoullos JD, Semprini AE, Frodsham LC. HIV and reproductive care—a review of current practice. BJOG. 2006;113:869–878
  7. Mandelbrot L, Heard I, Henrion-Geant E, Henrion R. Natural conception in HIV-negative women with HIV-infected partners. Lancet. 1997;349:850–851
  8. Sauer MV, Chang PL. Establishing a clinical program for human immunodeficiency virus 1-seropositive men to father seronegative children by means of in vitro fertilization with intracytoplasmic sperm injection. American journal of obstetrics and gynecology. 2002;186:627–633
  9. Cleary-Goldman J, Pena JE, Thornton MH, Robinson JN, D'Alton ME, Sauer MV. Obstetric outcomes of human immunodeficiency virus-1-serodiscordant couples following in vitro fertilization with intracytoplasmic sperm injection. Am J Perinatol. 2003;20:305–311
  10. Politch JA, Xu C, Tucker L, Anderson DJ. Separation of human immunodeficiency virus type 1 from motile sperm by the double tube gradient method versus other methods. Fertil Steril. 2004;81:440–447
  11. Gilling-Smith C, Emiliani S, Almeida P, Liesnard C, Englert Y. Laboratory safety during assisted reproduction in patients with blood-borne viruses. Hum Reprod. 2005;20:1433–1438
  12. Sauer MV, Chang PL. Posthumous reproduction in a human immunodeficiency virus-discordant couple. Am J Obstet Gynecol. 2001;185:252–253
  13. Sauer MV, Choi J. HIV seroconversion in a woman preparing for assisted reproduction: an inherent risk in caring for HIV-serodiscordant couples. Reprod Biomed Online. 2006;12:375–377
  14. Chu MC, Pena JE, Thornton MH, Sauer MV. Assessing the treatment efficacy of IVF with intracytoplasmic sperm injection in human immunodeficiency virus-1 (HIV-1) serodiscordant couples. Reprod Biomed Online. 2005;10:130–134
  15. Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS. 2007;21:1909–1914
  16. U.S. Centers for Disease Control and Prevention. 2005 Assisted reproductive technology success rates: national summary and fertility clinic reports. Atlanta, GA: CDC, National Center for Chronic Disease Prevention and Health Promotion; 2007;Available at: http://www.cdc.gov/ART/ART2005/index.htm
  17. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med. 2002;346:731–737
  18. Klein J, Pena JE, Thornton MH, Sauer MV. Understanding the motivations, concerns, and desires of human immunodeficiency virus 1-serodiscordant couples wishing to have children through assisted reproduction. Obstet Gynecol. 2003;101:987–994
  19. Saracco A, Musicco M, Nicolosi A, Angarano G, Arici C, Gavazzeni G, et al. Man-to-woman sexual transmission of HIV: longitudinal study of 343 steady partners of infected men. J Acquir Immune Defic Syndr. 1993;6:497–502
  20. Centers for Disease Control and Prevention. HIV-1 infection and artificial insemination with processed semen. MMWR Morb Mortal Wkly Rep. 1990;39:249;255–6
  21. Hanabusa H, Kuji N, Kato S, Tagami H, Kaneko S, Tanaka H, et al. An evaluation of semen processing methods for eliminating HIV-1. AIDS. 2000;14:1611–1616
  22. Muller CH, Coombs RW, Krieger JN. Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men. Andrologia. 1998;30(Suppl 1):15–22
  23. Brogi A, Presentini R, Solazzo D, Piomboni P, Costantino-Ceccarini E. Interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with a galactoglycerolipid associated with human sperm. AIDS Res Hum Retroviruses. 1996;12:483–489
  24. Quayle AJ, Xu C, Tucker L, Anderson DJ. The case against an association between HIV-1 and sperm: molecular evidence. J Reprod Immunol. 1998;41:127–136
  25. Kato S, Hanabusa H, Kaneko S, Takakuwa K, Suzuki M, Kuji N, et al. Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. AIDS. 2006;20:967–973
  26. Gilling-Smith C, Smith JR, Semprini AE. HIV and infertility: time to treat. There's no justification for denying treatment to parents who are HIV positive. BMJ. 2001;322:566–567
  27. Sauer MV. American physicians remain slow to embrace the reproductive needs of human immunodeficiency virus–infected patients. Fertil Steril. 2006;85:295–301

 M.V.S. has nothing to disclose. J.G.W. has nothing to disclose. N.C.D. has nothing to disclose. G.S.N. has nothing to disclose. P.V. has nothing to disclose. V.J. has nothing to disclose. M.M.G. has nothing to disclose.

PII: S0015-0282(08)00794-2

doi: 10.1016/j.fertnstert.2008.04.013

Fertility and Sterility
Volume 91, Issue 6 , Pages 2455-2460 , June 2009

Article Tools